MALLINCKRODT LLC
HAZELWOOD, MO

SUBMISSION TERMS AND CONDITIONS In consideration of Mallinckrodt receiving my Idea Submission, I hereby acknowledge that I have read and understand my rights and responsibilities per the Mallinckrodt Terms and Conditions set forth below. Specifically, I hereby acknowledge and agree to the following conditions: Mallinckrodt did not solicit the submission of my idea, suggestion or invention ("Idea") and is considering my Idea only at my request. I am voluntarily disclosing my Idea on a non-confidential basis and agree there is no confidential relationship established between myself and Mallinckrodt to treat my Idea in confidence or protect it in any way. I warrant that: 1) I am the true owner of my Idea, or I have the right to disclose the Idea and to enter into this Agreement on behalf of the true owner(s); and 2) there are no conflicting agreements that preclude the disclosure, assignment, sale or license of rights (including, without limitation, patent rights) of the Idea submission to Mallinckrodt. I grant Mallinckrodt the right to evaluate my Idea and I do hereby release Mallinckrodt from any liability in connection therewith. I understand that the submission of my Idea will not create a claim to Mallinckrodt’s ideas or inventions regardless of whether the submitted Idea is the same or similar to Mallinckrodt’s. I further understand that Mallinckrodt remains free to develop, acquire, improve and market its own ideas or inventions that are the same, similar and/or competitive with my Idea, that Mallinckrodt is not obligated to disclose these ideas or inventions and that nothing herein implies or constitutes a covenant not to compete. I understand that Mallinckrodt is not obligated to return any material submitted to it. I accept that my Idea may be included in an internal database of submitted ideas for review and evaluation and may be permanently retained by Mallinckrodt for archival keeping purposes. I understand and agree that Mallinckrodt does not have an obligation to compensate me for the submission or consideration of my idea and that Mallinckrodt does not have an obligation to license any patent or intellectual property rights protecting my idea. You must agree with the above terms to continue with your submission. SUBMISSION TERMS AND CONDITIONS In consideration of Mallinckrodt receiving my Idea Submission, I hereby acknowledge that I have read and understand my rights and responsibilities per the Mallinckrodt Terms and Conditions set forth below. Specifically, I hereby acknowledge and agree to the following conditions: Mallinckrodt did not solicit the submission of my idea, suggestion or invention ("Idea") and is considering my Idea only at my request. I am voluntarily disclosing my Idea on a non-confidential basis and agree there is no confidential relationship established between myself and Mallinckrodt to treat my Idea in confidence or protect it in any way. I warrant that: 1) I am the true owner of my Idea, or I have the right to disclose the Idea and to enter into this Agreement on behalf of the true owner(s); and 2) there are no conflicting agreements that preclude the disclosure, assignment, sale or license of rights (including, without limitation, patent rights) of the Idea submission to Mallinckrodt. I grant Mallinckrodt the right to evaluate my Idea and I do hereby release Mallinckrodt from any liability in connection therewith. I understand that the submission of my Idea will not create a claim to Mallinckrodt’s ideas or inventions regardless of whether the submitted Idea is the same or similar to Mallinckrodt’s. I further understand that Mallinckrodt remains free to develop, acquire, improve and market its own ideas or inventions that are the same, similar and/or competitive with my Idea, that Mallinckrodt is not obligated to disclose these ideas or inventions and that nothing herein implies or constitutes a covenant not to compete. I understand that Mallinckrodt is not obligated to return any material submitted to it. I accept that my Idea may be included in an internal database of submitted ideas for review and evaluation and may be permanently retained by Mallinckrodt for archival keeping purposes. I understand and agree that Mallinckrodt does not have an obligation to compensate me for the submission or consideration of my idea and that Mallinckrodt does not have an obligation to license any patent or intellectual property rights protecting my idea. You must agree with the above terms to continue with your submission. Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Mr. Trudeau has been president, chief executive officer and a director since June 2013. In anticipation of Mallinckrodt’s spin transaction with Covidien plc, Mr. Trudeau joined Covidien in February 2012 as a senior vice president and president of its Pharmaceuticals business. He joined Covidien from Bayer HealthCare LLC, the U.S. healthcare business of Bayer AG, where he served as chief executive officer from 2010 to 2012. In addition, he served as president of the global specialty medicine business unit in 2010. Mark Casey is general counsel at Mallinckrodt Pharmaceuticals. He has executive responsibility for all legal functions, including those related to litigation, intellectual property, environmental and regulatory matters, and mergers and acquisitions. Mr. Casey is a member of Mallinckrodt’s executive committee. Mr. Casey is a tenured attorney and executive with 30 years of experience in international business, litigation management across a range of matters, acquisitions and divestitures, and deep knowledge of intellectual property, regulatory and legal strategy, with 20 of those years in the healthcare industry and over ten years as general counsel.